C150H164F13N33O11 — CID 159915626
N-[[6-(7-acetyl-2,7-diazaspiro[3.5]nonan-2-yl)-3-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[6-(4-prop-1-en-2-ylpiperazin-1-yl)-3-pyridinyl]methyl]cyclopropane-1-carboxamide;N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;N-[[4-(1-prop-1-en-2-ylpiperidin-4-yl)phenyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide (PubChem CID 159915626) has the molecular formula C150H164F13N33O11 and a molecular weight of 2852.16 g/mol. Its IUPAC name is N-[[6-(7-acetyl-2,7-diazaspiro[3.5]nonan-2-yl)-3-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[6-(4-prop-1-en-2-ylpiperazin-1-yl)-3-pyridinyl]methyl]cyclopropane-1-carboxamide;N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;N-[[4-(1-prop-1-en-2-ylpiperidin-4-yl)phenyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide.
| Compound Name | N-[[6-(7-acetyl-2,7-diazaspiro[3.5]nonan-2-yl)-3-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[6-(4-prop-1-en-2-ylpiperazin-1-yl)-3-pyridinyl]methyl]cyclopropane-1-carboxamide;N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;N-[[4-(1-prop-1-en-2-ylpiperidin-4-yl)phenyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 159915626 |
| Molecular Formula | C150H164F13N33O11 |
| Molecular Weight | 2852.16 g/mol |
| Exact Mass | 2850.31 |
| IUPAC Name | N-[[6-(7-acetyl-2,7-diazaspiro[3.5]nonan-2-yl)-3-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]cyclopropane-1-carboxamide;1-[6-[[6-(difluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]-N-[[6-(4-prop-1-en-2-ylpiperazin-1-yl)-3-pyridinyl]methyl]cyclopropane-1-carboxamide;N-[[5-(7-prop-1-en-2-yl-2,7-diazaspiro[3.5]nonan-2-yl)-2-pyridinyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide;N-[[4-(1-prop-1-en-2-ylpiperidin-4-yl)phenyl]methyl]-1-[6-[[6-(trifluoromethyl)-3-pyridinyl]methoxy]pyridazin-3-yl]cyclopropane-1-carboxamide |
| SMILES | C=C(C)N1CCC(c2ccc(CNC(=O)C3(c4ccc(OCc5ccc(C(F)(F)F)nc5)nn4)CC3)cc2)CC1.C=C(C)N1CCC2(CC1)CN(c1ccc(CNC(=O)C3(c4ccc(OCc5ccc(C(F)(F)F)nc5)nn4)CC3)nc1)C2.C=C(C)N1CCC2(CC1)CN(c1ccc(CNC(=O)C3(c4ccc(OCc5ccc(C(F)F)nc5)nn4)CC3)nc1)C2.C=C(C)N1CCN(c2ccc(CNC(=O)C3(c4ccc(OCc5ccc(C(F)F)nc5)nn4)CC3)cn2)CC1.CC(=O)N1CCC2(CC1)CN(c1ccc(CNC(=O)C3(c4ccc(OCc5ccc(C(F)(F)F)nc5)nn4)CC3)cn1)C2 |
| InChI | InChI=1S/C31H34F3N7O2.C31H35F2N7O2.C30H32F3N7O3.C30H32F3N5O2.C28H31F2N7O2/c1-21(2)40-13-11-29(12-14-40)19-41(20-29)24-5-4-23(35-17-24)16-37-28(42)30(9-10-30)25-7-8-27(39-38-25)43-18-22-3-6-26(36-15-22)31(32,33)34;1-21(2)39-13-11-30(12-14-39)19-40(20-30)24-5-4-23(34-17-24)16-36-29(41)31(9-10-31)26-7-8-27(38-37-26)42-18-22-3-6-25(28(32)33)35-15-22;1-20(41)39-12-10-28(11-13-39)18-40(19-28)25-6-3-21(14-35-25)15-36-27(42)29(8-9-29)23-5-7-26(38-37-23)43-17-22-2-4-24(34-16-22)30(31,32)33;1-20(2)38-15-11-24(12-16-38)23-6-3-21(4-7-23)17-35-28(39)29(13-14-29)25-9-10-27(37-36-25)40-19-22-5-8-26(34-18-22)30(31,32)33;1-19(2)36-11-13-37(14-12-36)24-7-4-20(15-32-24)16-33-27(38)28(9-10-28)23-6-8-25(35-34-23)39-18-21-3-5-22(26(29)30)31-17-21/h3-8,15,17H,1,9-14,16,18-20H2,2H3,(H,37,42);3-8,15,17,28H,1,9-14,16,18-20H2,2H3,(H,36,41);2-7,14,16H,8-13,15,17-19H2,1H3,(H,36,42);3-10,18,24H,1,11-17,19H2,2H3,(H,35,39);3-8,15,17,26H,1,9-14,16,18H2,2H3,(H,33,38) |
| InChIKey | NXSYVSFIBFRIMN-UHFFFAOYSA-N |
| XLogP | 22.19 |
| TPSA | 482.79 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 46 |
| Heavy Atoms | 207 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2852.16 |
| LogP ≤ 5 | 22.19 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 38 |